May 3, 2005 by Stephen D. SimpsonOshkosh's Growth EnginesStrong performance in the fire/rescue and defense markets continues to drive this specialty truck builder.
May 2, 2005 by Stephen D. SimpsonChewing on Tyson's ResultsA better-than-expected quarter raises the hope that operations have stabilized and growth is back in the story.
May 2, 2005 by Stephen D. SimpsonTracking the Numbers at Genesee & WyomingGrowth slowed in the first quarter, but the railroad company is still a well-placed small operator.
May 2, 2005 by Stephen D. SimpsonFeast or Famine at SYSCO?SYSCO showed some real growth in the third quarter, but valuation is still troublesome.
Apr 29, 2005 by Stephen D. SimpsonCP's Nice Ride on the RailsCanadian Pacific profits from increased coal demand and grain production.
Apr 29, 2005 by Stephen D. SimpsonExxonMobil: A Big Oil Slick?Declines in hydrocarbon production hurt first-quarter results and might indicate future troubles.
Apr 29, 2005 by Stephen D. SimpsonChevronTexaco Tries to Do More With LessLower hydrocarbon production and refinery margins lead to a disappointing quarter.
Apr 29, 2005 by Stephen D. SimpsonLincoln Electric's Power CycleIt had a good quarter because of international sales, but the U.S. market is a concern.
Apr 29, 2005 by Stephen D. SimpsonArch Capital Keeps It GoingDespite a tough insurance environment, the company continues to grow.
Apr 28, 2005 by Stephen D. SimpsonIs This the Renter to Own?Aaron Rents continues to post same-store sales growth that puts the competition to shame.
Apr 28, 2005 by Stephen D. SimpsonCB&I Books to the FutureThe first quarter looked a bit slow, but future bookings suggest good growth lies ahead.
Apr 28, 2005 by Stephen D. SimpsonBristol-Myers: Hang in ThereGenerics are wreaking havoc on growth, but patient investors can pin hopes on drugs now in the pipeline.
Apr 28, 2005 by Stephen D. SimpsonGlaxo Works to Stay on TrackWith FDA issues near resolution, Glaxo should continue its respectable growth trajectory.
Apr 28, 2005 by Stephen D. SimpsonStandby Drugs Sustain AstraZenecaSales are good now, but what will a weak pipeline mean in a few years?
Apr 28, 2005 by Stephen D. SimpsonNovo Nordisk Could Use a BoostInvestors reacted badly to first-quarter results, but there's still a lot to like about the company.
Apr 27, 2005 by Stephen D. SimpsonVCA Antech Sure Can FetchSame-store sales growth and margin improvements drive another good quarter for VCA Antech.
Apr 27, 2005 by Stephen D. SimpsonCents and Websense-abilityMany worry about competition, but that's nothing new in this business, and growth rolls on.
Apr 27, 2005 by Stephen D. SimpsonRoll, Tidewater, Roll!Improving utilization and day rates leads to a year-over-year doubling of earnings.
Apr 27, 2005 by Stephen D. SimpsonGoing to Ultra Petroleum's WellThis small independent gas producer continues to pile on the growth with higher production volumes.
Apr 27, 2005 by Stephen D. SimpsonBecton, Dickinson's Boring ReliabilityThis broadly diversified medical device company doesn't grow fast, but it is consistent.
